Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Anafortan
2. Avacan
3. Avapyrazone
4. Camylofin
5. Camylofin Hydrochloride
6. Camylofine
1. 5892-41-1
2. Camylofin Hydrochloride
3. Camylofin Dihydrochloride
4. Camylofin Hcl
5. Camylofine Hydrochloride
6. Belosin
7. Avocan
8. Camylophenine Dihydrochloride
9. Acamylophenine Hydrochloride
10. Acamylophenine Dihydrochloride
11. 5892-41-1 (hcl)
12. Acamylophenine Hcl
13. 3-methylbutyl {[2-(diethylamino)ethyl]amino}(phenyl)acetate Dihydrochloride
14. Acamylophenine Hydrochloride (jan)
15. Acamylophenine Hydrochloride [jan]
16. Isopentyl 2-((2-(diethylamino)ethyl)amino)-2-phenylacetate Dihydrochloride
17. Mo02h82c7m
18. Benzeneacetic Acid, Alpha-((2-(diethylamino)ethyl)amino)-, 3-methylbutyl Ester, 2hcl (9ci)
19. Nsc-759249
20. Camylofin Chlorhydrate
21. Chembl4303602
22. Schembl12481408
23. Chebi:31158
24. Dtxsid70974421
25. Mfcd00079040
26. 3-methylbutyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate,dihydrochloride
27. Camylofin Hydrochloride [mart.]
28. Camylofine Dihydrochloride [mi]
29. Ccg-213987
30. Camylofin Hydrochloride [who-dd]
31. Sw220091-1
32. D01759
33. Sr-01000872770
34. Sr-01000872770-1
35. W-110066
36. Q23766546
37. Camylofine Dihydrochloride, Analytical Standard, For Drug Analysis
38. Isopentyl -(2-diethylaminoethylamino)phenylacetate Dihydrochloride
39. 3-methylbutyl {[2-(diethylamino)ethyl]amino}(phenyl)acetate--hydrogen Chloride (1/2)
40. 3-methylbutyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate;dihydrochloride
41. Isopentyl 2-(2-diethylaminoethylamino)-2-phenylacetate Dihydrochloride
Molecular Weight | 393.4 g/mol |
---|---|
Molecular Formula | C19H34Cl2N2O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 12 |
Exact Mass | 392.1997337 g/mol |
Monoisotopic Mass | 392.1997337 g/mol |
Topological Polar Surface Area | 41.6 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 311 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
94
PharmaCompass offers a list of Camylofin Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Camylofin Dihydrochloride manufacturer or Camylofin Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camylofin Dihydrochloride manufacturer or Camylofin Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Camylofin Dihydrochloride API Price utilized in the formulation of products. Camylofin Dihydrochloride API Price is not always fixed or binding as the Camylofin Dihydrochloride Price is obtained through a variety of data sources. The Camylofin Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Camylofin Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Camylofin Dihydrochloride, including repackagers and relabelers. The FDA regulates Camylofin Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Camylofin Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Camylofin Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Camylofin Dihydrochloride supplier is an individual or a company that provides Camylofin Dihydrochloride active pharmaceutical ingredient (API) or Camylofin Dihydrochloride finished formulations upon request. The Camylofin Dihydrochloride suppliers may include Camylofin Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Camylofin Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Camylofin Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Camylofin Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Camylofin Dihydrochloride GMP manufacturer or Camylofin Dihydrochloride GMP API supplier for your needs.
A Camylofin Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Camylofin Dihydrochloride's compliance with Camylofin Dihydrochloride specifications and serves as a tool for batch-level quality control.
Camylofin Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Camylofin Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Camylofin Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Camylofin Dihydrochloride EP), Camylofin Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Camylofin Dihydrochloride USP).